Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study
Open Access
- 30 March 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 90, 104547
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020
- Instituto de Salud Carlos III
- Medical Research Council
- National Institutes of Health
- Tatiana Pérez de Guzmán el Bueno Foundation
- National Institute on Aging
- National Institute for Health and Care Research
- Alzheimer's Association
- Alzheimer's Society
- Deutsche Forschungsgemeinschaft
- EU Joint Programme – Neurodegenerative Disease Research
- Fondation Jérôme Lejeune
- Wellcome Trust
This publication has 35 references indexed in Scilit:
- Astrocyte Biomarkers in Alzheimer’s DiseaseTrends in Molecular Medicine, 2019
- Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegenerationActa Neuropathologica Communications, 2019
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyThe Lancet Neurology, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathiesJournal of Neuroinflammation, 2017
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisThe Lancet Neurology, 2016
- Dementia in Down's syndromeThe Lancet Neurology, 2016
- Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s diseaseBrain, 2016
- [Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities].2013
- Characterization of Antibodies that Detect Human GFAP after Traumatic Brain InjuryBiomarker Insights, 2012